US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist
  • 60.990
  • +0.970+1.62%
Close Mar 31 16:00 ET
  • 60.900
  • -0.090-0.15%
Post 20:01 ET
124.10BMarket Cap-13.83P/E (TTM)

About Bristol-Myers Squibb Company

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Company Profile

SymbolBMY
Company NameBristol-Myers Squibb
Listing DateJun 1, 1969
Issue Price40.50
Founded1933
CEODr. Christopher S. Boerner, PhD
MarketNYSE
Employees34100
Fiscal Year Ends12-31
AddressRoute 206 & Province Line Road
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08543
Phone1-609-252-4621

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Christopher S. Boerner, PhD
  • Chairman of the Board and Chief Executive Officer
  • 18.79M
  • Amanda Ahn Poole
  • Executive Vice President and Chief People Officer
  • --
  • Gregory Scott Meyers
  • Executive Vice President, Chief Digital Officer and Chief Technology Officer
  • --
  • David V. Elkins
  • Executive Vice President and Chief Financial Officer
  • 8.71M
  • Adam Lenkowsky
  • Executive Vice President and Chief Commercialization Officer
  • --
  • Dr. Samit Hirawat, M.D.
  • Executive Vice President, Chief Medical Officer and Head of Development
  • 8.59M
  • Dr. Robert M. Plenge, M.D.,PhD
  • Executive Vice President, Chief Research Officer and Head of Research
  • --
  • Phil Holzer
  • Senior Vice President, Principal Accounting Officer and Controller
  • --
  • Karin Shanahan
  • Executive Vice President, Global Product Development and Supply
  • 6.57M
  • Cari Gallman
  • Executive Vice President, Corporate Affairs
  • --
  • Sandra Leung
  • Executive Vice President and General Counsel
  • 7.01M
  • Lynelle Hoch
  • President, Cell Therapy Organization
  • --
  • Benjamin J. Hickey, M.B.A.
  • President, RayzeBio Organization
  • --
  • Phyllis R. Yale
  • Independent Director
  • 380.00K
  • Paula A. Price
  • Independent Director
  • 380.00K
  • Theodore R. Samuels
  • Lead Independent Director
  • 440.00K
  • Peter J. Arduini
  • Independent Director
  • 376.79K
  • Michael R. McMullen
  • Independent Director
  • 185.86K
  • Derica W. Rice
  • Independent Director
  • 390.00K
  • Dr. Manuel Hidalgo Medina, M.D.,PhD
  • Independent Director
  • 350.00K
  • Dr. Karen H. Vousden, PhD
  • Independent Director
  • 350.00K
  • Dr. Julia A. Haller, M.D.
  • Independent Director
  • 390.00K
  • Dr. Deepak L. Bhatt, M.D.,M.P.H.
  • Independent Director
  • 350.00K

Market Insights

Donald Trump Donald Trump

Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.

Unlock Now
Discussing
北水爆買!中國資產能否延續漲勢?
3月17日早盤,地產代理、物業服務及管理等板塊漲幅明顯,貝殼-W早盤漲逾4%,碧桂園服務漲逾9%。政策消息面上,兩部門發文落實專項債支持收地,中房協組織民營房企座談會。中國資產本輪火爆行情還能持續多久?你會如何投資? Show More
focus on technology stocks
Top tech company strong as always.